ArticleMetabolic brain disease2025

LCN2 blockade mitigating metabolic dysregulation and redefining appetite control in type 2 diabetes.

Cifuentes-Mendiola Saúl Ernesto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.